Filing Details
- Accession Number:
- 0000711377-13-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-29 15:03:58
- Reporting Period:
- 2013-07-26
- Filing Date:
- 2013-07-29
- Accepted Time:
- 2013-07-29 15:03:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187556 | M Lon Bohannon | Neogen Corp 620 Lesher Place Lansing MI 48912 | President & Chief Operating Of | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-07-26 | 12,771 | $57.22 | 144,803 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold under a 10b5-1(c) plan filed by the Registrant on 7/12/2013
Billionaire Hedge Funds
